Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 CausalMutation disease CGI
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 Biomarker disease HPO
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 Biomarker disease BEFREE The median age at CMM diagnosis (P =.70) and the median numbers of CMMs (P =.73) did not differ between CMM case subjects from CDKN2A versus CDK4 families. 10861313 2000
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE The CDKN2A gene has been implicated in cutaneous malignant melanoma (CMM) in about 40% of families with linkage to chromosome 9p21, while a small proportion of families have mutations in the CDK4 gene. 10874641 1999
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE : Inherited mutations in the CDKN2A tumor suppressor gene, which encodes the p16(INK4a) protein, and in the cyclin-dependent kinase 4 (CDK4) gene confer susceptibility to cutaneous malignant melanoma. 10922411 2000
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE Although mutations in two genes, CDKN2A and CDK4, have been shown to confer an increased risk of CMM, they account for only 20%-25% of families with multiple cases of CMM. 12844286 2003
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE We performed a genome-wide scan of two Danish pedigrees with multiple cases of OMM (N = 10) and CMM (N = 3) and other malignancies (with no germline mutations in CDKN2A, CDK4, BRCA1, and BRCA2) to identify melanoma susceptibility genes. 16174859 2005
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 Biomarker disease BEFREE CDKN2A and CDK4 are the only known high-penetrant genes conferring proneness to cutaneous melanoma. 20132244 2010
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma. 21801156 2011
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE Integrative sequencing of cutaneous melanoma metastases using different sequencing platforms revealed a new somatic point mutation in HRAS and a structural rearrangement affecting CDKN2C (a CDK4 inhibitor). 23174022 2013
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 Biomarker disease BEFREE CDKN2A and CDK4 are high risk susceptibility genes for cutaneous malignant melanoma. 23384855 2013
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE We found an association between the risk of CMM and peripheral blood mononuclear cell methylation levels of TNFα [odds ratio (OR)=1.11, 95% confidence interval (CI)=1.03-1.18], CDK4 (OR=0.76, 95% CI=0.64-0.91), and MLH1 (OR=1.12, 95% CI=1.02-1.22). 25026000 2014
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 Biomarker disease BEFREE This is the first estimate of the contribution of BAP1 and CDK4 to a population-based sample of CMM and supports the previously reported estimate of CDKN2A germline mutation prevalence. 25787093 2015
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE To conclude, we propose that mutation screening of CDKN2A and CDK4 in Denmark should predominantly be performed in families with at least 3 cases of CM. 25803691 2015
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
Entrez Id: 1019
Gene Symbol: CDK4
CDK4
0.500 GeneticVariation disease BEFREE We identified germline mutations in highly CM-associated genes (CDKN2A and CDK4) and low/medium-penetrance variants (MC1R and MITF) in patients with multiple primary CMs or individuals with one or more CM and a positive family history for CM or pancreatic cancer among first- or second-degree relatives. 27473757 2016